Oppenheimer analyst Leland Gershell downgrades PLx Pharma (NASDAQ:PLXP) from Outperform to Perform.
Keybanc Maintains Overweight Rating for Paycom Software: Here’s What You Need To Know
Keybanc has decided to maintain its Overweight rating of Paycom Software (NYSE:PAYC) and raise its price target from $390.00 to $432.00.
Shares of Paycom Software are trading up 0.98% over the last 24 hours, at $397.78 per share.